Lipocine Inc. (LPCN)
NASDAQ · Healthcare
Lipocine Inc. Shareholder Equity 2012–2025
Lipocine Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lipocine Inc. shareholder equity as of December 31, 2025: 14.5M, a 31.05% decrease year-over-year.
- Lipocine Inc. shareholder equity for 2025 were 14.5M, a 31.05% decrease from 2024.
- Lipocine Inc. shareholder equity for 2024 were 21.0M, a 3.08% increase from 2023.
- Lipocine Inc. shareholder equity for 2023 were 20.4M, a 42.84% decrease from 2022.
- Lipocine Inc. shareholder equity for 2022 were 35.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lipocine Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $14 |
| 2024 | $21 |
| 2023 | $20 |
| 2022 | $36 |
| 2021 | $46 |
| 2020 | $15 |
| 2019 | $6 |
| 2018 | $9 |
| 2017 | $19 |
| 2016 | $26 |
| 2013 | $45 |
| 2012 | $5 |
Lipocine Inc. Shareholder Equity — FAQ
Lipocine Inc. (LPCN) shareholder equity over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LPCN's shareholder equity history?
The chart and table above show Lipocine Inc.'s shareholder equity by year and by quarter, including the growth rate.